Skip to content

Author

Jie Feng

We have 1 of 11 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

TET1 Inhibition Promotes Therapeutic Sensitivity in TP53‐Mutant GBM by Influencing Genome Fragility and Altering TAMs Biology

An association between reduced P53 function and increased expression of the epigenetic regulator TET1 in GBM models is identified, suggesting that TET1 may serve as a potential mediator of therapy resistance and a promising therapeutic target in TP53mut GBM.

Zhuonan Pu, Jinqiu Liu, Yuxuan Deng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.